Document for Obstetric Patients Who Refuse Consent for Blood and Blood Product Administration, Including Jehovah s Witnesses

Similar documents
Plasma-derived products Information for patients

Crossmatching and Issuing Blood Components; Indications and Effects.

Frequently Asked Questions on Blood Donation

A Patient s Guide to Blood Components and Products

Pearson's Comprehensive Medical Assisting Administrative and Clinical Competencies

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CISPLATIN + ETOPOSIDE ORAL/INTRAVENOUS

PHLEBOTOMIST. person trained to draw blood from a patient for clinical or medical testing, transfusions, donations, or research.

D-Gam 250 micrograms/ml. Solution for injection. human anti-d immunoglobulin

Blood Conservation. To introduce the learner to the basic concepts of blood conservation!! Learning Outcomes

Patient identifier/label: Page 1 of 7 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM EC-T: EPIRUBICIN / CYCLOPHOSPHAMIDE - DOCETAXEL

Patient's surname/family name. Patient's first names. Date of birth. Responsible health professional. Job title. NHS number (or other identifier)

Package leaflet: Information for the user

2. What you need to know before you are given Konakion MM. Package Leaflet: Information for the patient

Non-Medical Authorisation Course TRANSFUSION ALTERNATIVES. East Midlands Regional Transfusion Committee

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CHOP 21 +/- RITUXIMAB. Patient s first names.

BLOOD TRANSFUSIONS. Answers. To Your. Questions

Principles of Anatomy and Physiology

Answers. To Your. Questions

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE (HIGH DOSE)

Patient identifier/label: Page 1 of 5 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CABOZANTINIB. Patient s first names.

X-Plain Blood Transfusion Reference Summary

All institutions that transfuse blood components and products should implement national and local policies and written procedures for:

Patient identifier/label: Page 1 of 5 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM BEVACIZUMAB. Patient s first names. Date of birth.

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM ABVD. Patient s first names.

BLOOD COMPONENT SUPPORT OF RhD NEGATIVE INDIVIDUALS

BLOOD TRANSFUSIONS. Answers. To Your. Questions

Blood 1 of 28 Boardworks Ltd 2012

BLOOD TRANSFUSION. Dr Lumka Ntabeni

PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FERRERI / IELSG PROTOCOL. Patient s first names. Date of birth

The Bleeding Jehovah s Witness: A Nightmare Scenario?

Fresh Frozen Plasma (FFP) and Cryoprecipitate Patient information

If you want to learn more about this study, you are welcome to read the full consent form and the patient handbook.

Red cell antigens and blood group antibodies

Blood. Biol 105 Lecture 14 Chapter 11

Diagnostic and therapeutic pleural aspiration

Privigen solution for infusion

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

TRANSFUSION SAFETY 101 ARE YOU SMARTER THAN A BLOOD BANKER?

A Guide To Safe Blood Transfusion Practice

4/5/17. Blood. Blood. Outline. Blood: An Overview. Functions of Blood

Chapter 19 Cardiovascular System Blood: Functions. Plasma

What You Need to Know About Blood Transfusion. Elianna Saidenberg May 2014

UNIVERSITY OF WASHINGTON MEDICAL CENTER Men s Health Center and Male Fertility Laboratory Sperm & Testis Cryopreservation Program Patient NAME and ID

Chapter 13 The Blood

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM ZOLEDRONIC ACID. Patient s first names.

Transfusion Triggers. Richard Soutar January 2012

THE KENYA POLYTECHNIC UNIVERSITY COLLEGE

OSPITAL IAISON OMMITTEE

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

NICE guideline Published: 18 November 2015 nice.org.uk/guidance/ng24

Functions of Blood. Transport. Transport. Defense. Regulation. Unit 6 Cardiovascular System: Blood

BLEEDING DISORDERS. JC Opperman 2012

Blood Cells Med Terms Quiz

Percutaneous nephrolithotomy (PCNL)

PROPOSED TECHNICAL REQUIREMENTS BLOOD AND BLOOD COMPONENTS. File 1 DRAFT FOR CONSULTATION PURPOSES ONLY

Administration of blood components. Tina Parker - Transfusion Practitioner

Major Haemorrhage Transfusion Pathway

BIOCHEMISTRY of BLOOD

Package leaflet: Information for the patient. Konakion MM Ampoules 10mg/ml solution for injection and oral solution Phytomenadione (vitamin K 1 )

Blood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.

COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH)

What are the functions of blood?

WHICH OF THE FOLLOWING COMPRISE A

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR THAWING AND TRANSFER OF CRYOPRESERVED EMBRYOS. I and

Average adult = 8-10 pints of blood. Functions:

BLOOD RUNS THROUGH YOUR BODY

MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE

Blood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood?

PreAssignment #14 The Endocrine and Cardiovascular Systems Name: Section #:

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS

A Patient s guide to. Blood Transfusions and Human Tissue Transplant

Introduction to Haematology. Prof Roger Pool Department of Haematology University of Pretoria

Lipomodelling / Fat grafting

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Laparoscopic radical nephrectomy

Essential Transfusion. Medical Students

Anaemia Patient information

Unit Seven Blood and Immunity

Patient agreement to investigation or treatment. Emergency Spinal Discectomy/Decompression. Patient details (or pre-printed label)

Blood CHAPTER. Lesson Objectives. Lesson Vocabulary. Introduction. Structure and Functions of Blood. Chapter 1. Blood

New Advances in Transfusion EM I LY CO BERLY, M D

Hematology. The Study of blood

CAUTION: Refer to the Document Library for the most recent version of this document. Cryoprecipitate Transfusion Guideline for Practice.

Arthroscopic subacromial decompression (ASD) with or without AC joint removal

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

BLOOD. Dr. Vedat Evren

PACKAGE LEAFLET: INFORMATION FOR THE USER. octaplaslg mg/ml solution for infusion Human plasma proteins

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Increased Number of Red Blood Cells (Polycythemia) Basics

Blood products and plasma substitutes

IRB USE ONLY Approval Date: September 10, 2013 Expiration Date: September 10, 2014

Guidelines for Use of Canine Blood Components

Blood. Plasma. The liquid part of blood is called plasma. 1. Pale yellow fluid; forms more than half the blood volume.

Babies receiving a blood transfusion. Information for parents and carers

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Functions of Blood. 1. Transportation 2. Protection against invasion 3. Blood clotting 4. Regulation. Blood: Functions Blood clotting

Transcription:

Document for Obstetric Patients Who Refuse Consent for Blood and Blood Product Administration, Including Jehovah s Witnesses Patient addressograph Label This form must only be used for the refusal of blood products by adults, who have capacity to consent or refuse treatment. To be completed by the patient (Please read carefully before completing and signing this form, and ask any questions you may have of the healthcare professional reviewing the form with you) Please clearly tick where applicable:- I am a Jehovah s Witness I carry a Health Care Advance Directive. I have discussed this with the health care professional completing the Blood Product Refusal Form with me I have chosen to refuse blood product transfusion or products, but am not a Jehovah s Witness - 1 -

Please sign and date in the appropriate box below (I will / I will not for each product listed). If you have any questions please ask your doctor or midwife I will T Anti D (Immunoglobulin) Rhesus disease can largely be prevented by having an injection of a medication called anti-d immunoglobulin. This can help to avoid a process known as sensitisation, which is when a woman with RhD negative blood is exposed to RhD positive blood and develops an immune response to it. This can also affect future pregnancies. Blood (packed Red Cells) This is with most of the cells (white blood cells, platelets, clotting factors) removed and a nutritive solution added. Red blood cells carry oxygen around your body. A transfusion can be lifesaving. Cryoprecipitate This is part of the which is separated from the red blood cells and contains clotting factors. It can help significantly to control bleeding and can therefore be lifesaving. Cell Salvaged Blood When surgery creates bleeding, this blood can be sucked up from the surgical site, washed and transfused back to the patient through a vein. The blood is yours and does not leave the room. A continuous connection (though not a complete, blood filled circuit) between yourself and the suction machine can be attempted in a planned procedure, but not be guaranteed in an emergency N/A - 2 -

I will T Erythropoietin (EPO) Is a glycoprotein hormone that controls erythropoiesis, or red blood cell production Factor V111 (Voncento) For prophylaxis and treatment of haemorrhage or surgical bleeding in patients with Von Willibrand Disease Factor V11A NovoSev (Novoseven) Indicated for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures No (to order ) Factor V111 (Advate) Antihaemophilic factor indicated for adults and children with Haemophilia A Factor V1111 (Benefix) Antihaemophilic factor for adults and children with Haemophilia B Fresh Frozen Plasma Refers to the liquid portion of that has been frozen and preserved after a blood donation and will be used for blood transfusion. Granulocytes Neutrophils- Granulocyte transfusions can be used as supportive therapy in patients with life-threatening neutropenia caused by bone marrow failure or in patients with neutrophil dysfunction. (To Order) - 3 -

I will T Human Albumin Solution Albumin is found in blood. It is taken from whole blood and is given to patients with a low albumin Octaplas Human Plasma Proteins Other Immunoglobulins Manufactured from large pools of donor plasma Examples:- Tetanus Hepatitis B Rabies Platelets Small colourless disc-shaped cell fragments without a nucleus, found in large numbers in blood and involved in clotting. (To Order) Prothrombin Complex Concentrate (Octaplex) Clotting factors that are taken from human plasma and processed into a powder for storage. p Patient s declaration I confirm that I have been informed about the available alternatives to blood/blood product transfusion and/or blood conservation methods, if applicable to the clinical situation, including their effectiveness and the risks. I understand the information I have been given. I withhold my consent to the blood-related options indicated above in relation to all operations, investigations or treatment I may undergo until I withdraw my refusal either by completing the box at the end of the form, or by expressing this wish verbally to a health care professional. The implications of this have been explained to me and I understand them. My refusal of blood and any blood components stated above will remain in force even if I become unconscious and /or affected by medication, or any condition rendering me incapable of expressing my wishes and consent to treatment options. I intend to refuse blood and blood products stated above even if the clinician/s treating me consider them necessary to save my life. - 4 -

I understand and that by refusing the products as signed above, I risk serious long term injury and death that might be avoided by the administration of blood and/or blood products. I intend to refuse blood and blood products stated above even if the clinician/s treating me consider them necessary to save the life of my baby. I understand and that by refusing the products as signed above, I risk serious long term injury and death to my baby that might be avoided by the administration of blood and/or blood products. I fully understand the implications of my position and the implications for my baby, regarding blood / blood component transfusion and am exercising my own choice, free from any external influence. Signature of patient:.. Date:.. Name (print):. To be completed by Health Care Professional I confirm that I am a health care professional with sufficient knowledge about the issue and implications of consent to blood products to properly inform the patient about the matters contained in this form. A full note of the discussions with the patient has been made in their medical records, clearly giving a date and time of the explanation, including details of the person giving it. I confirm that I have considered the patient s capacity and I am satisfied that they have the capacity to refuse blood and any blood components. I have confirmed with the patient that they have no further questions and that they understand the implications of signing this refusal form to their life, and to the life of their baby. Signature of Health Care Professional: Date: Name and Title (print):. If the patient later decides to withdraw refusal and decides to blood and/or blood component transfusion, the following section must be completed: Patient signature (unless oral consent given) Date Signature of Health Care Professional: Date: Name and Title (print):.. - 5 -